OMNIAB, INC. Other Noncash Income (Expense)
OMNIAB, INC. (OABI) reported Other Noncash Income (Expense) of -$63.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-06
- OMNIAB, INC. other noncash income (expense) for the quarter ending 2026-06-30 was -$6.00K.
- OMNIAB, INC. other noncash income (expense) for the quarter ending 2026-03-31 was -$57.00K.
- OMNIAB, INC. other noncash income (expense) for the quarter ending 2025-12-31 was -$608.00K.
- OMNIAB, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$33.00K, a 466.67% decline year-over-year.
- OMNIAB, INC. other noncash income (expense) for fiscal 2025 was -$761.00K.
- OMNIAB, INC. other noncash income (expense) for fiscal 2024 was -$544.00K.
- OMNIAB, INC. other noncash income (expense) for fiscal 2023 was -$100.00K.
- OMNIAB, INC. other noncash income (expense) for fiscal 2022 was -$190.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$63.00K 10-Q · filed 2026-08-06 | -$671.00K derived: sum of 3 quarters · filed 2026-08-06 | -$704.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$57.00K 10-Q · filed 2026-05-07 | -$665.00K derived: sum of 2 quarters · filed 2026-05-07 | -$698.00K derived: sum of 3 quarters · filed 2026-05-07 | -$796.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$608.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$641.00K derived: sum of 2 quarters · filed 2026-03-04 | -$739.00K derived: sum of 3 quarters · filed 2026-08-06 | -$761.00K 10-K · filed 2026-03-04 | ||
| 2025-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$131.00K derived: sum of 2 quarters · filed 2026-08-06 | -$153.00K 10-Q · filed 2025-11-04 | -$173.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$120.00K 10-Q · filed 2026-08-06 | -$140.00K derived: sum of 3 quarters · filed 2026-08-06 | -$131.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$22.00K 10-Q · filed 2026-05-07 | -$42.00K derived: sum of 2 quarters · filed 2026-05-07 | -$33.00K derived: sum of 3 quarters · filed 2026-05-07 | -$577.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$11.00K derived: sum of 2 quarters · filed 2026-03-04 | -$555.00K derived: sum of 3 quarters · filed 2026-03-04 | -$544.00K 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$535.00K derived: sum of 2 quarters · filed 2025-11-04 | -$524.00K 10-Q · filed 2025-11-04 | -$534.00K derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$533.00K 10-Q · filed 2025-08-06 | -$543.00K derived: sum of 3 quarters · filed 2025-08-06 | -$97.00K derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $11.00K 10-Q · filed 2025-05-08 | $1.00K derived: sum of 2 quarters · filed 2025-05-08 | $447.00K derived: sum of 3 quarters · filed 2025-05-08 | -$117.00K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $436.00K derived: sum of 2 quarters · filed 2025-03-18 | -$128.00K derived: sum of 3 quarters · filed 2025-03-18 | -$100.00K 10-K · filed 2025-03-18 | ||
| 2023-09-30 | $446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$118.00K derived: sum of 2 quarters · filed 2024-11-12 | -$90.00K 10-Q · filed 2024-11-12 | -$413.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$536.00K 10-Q · filed 2024-08-08 | -$63.00K 10-Q · filed 2023-08-10 | -$859.00K derived: sum of 3 quarters · filed 2024-08-08 | -$689.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $28.00K 10-Q · filed 2024-05-09 | -$295.00K derived: sum of 2 quarters · filed 2024-05-09 | -$125.00K derived: sum of 3 quarters · filed 2024-05-09 | -$438.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$153.00K derived: sum of 2 quarters · filed 2024-03-25 | -$466.00K derived: sum of 3 quarters · filed 2024-03-25 | -$190.00K 10-K · filed 2024-03-25 | -$20.00K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$143.00K derived: sum of 2 quarters · filed 2023-11-09 | $133.00K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$37.00K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | $276.00K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$64.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |